Subgroup analysis indicated that patients with Gli1 positive expression could have a significant poorer survival than others at the same depth of tumor invation (stage T3-T4), lymph node metastasis (positive) or same TNM stage (stage III-IV). The gene discussed is GLI1; the disease is neoplasm.